Skip to content

Pilot test of feasibility and effects of the implementation of a self-management support intervention for patients with cancer and their family caregivers to reduce pain and related symptoms

Pilot test of feasibility and effects of the implementation of a self-management support intervention for patients with cancer and their family caregivers to reduce pain and related symptoms - ANtiPain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00005034
Enrollment
48
Registered
2013-08-15
Start date
2013-12-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oncology patients with cancer-related pain and associated symptoms R52.9

Interventions

Group 1: Intervention group: Patients in the intervention group will be offered pain self-management support by the APNpain who follows a detailed intervention protocol. For patients in the interventi

Sponsors

Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: In-patients of a palliative care consultation service; Patients will be included if they have cancer-related pain >3/10 (NRS 0 = no pain to 10 = worst pain imaginable); will be discharged from hospital with need for pain self-management, have an expected life expectancy of =3 months, understand, read and write German, and have access to a telephone.

Exclusion criteria

Exclusion criteria: Patients will be excluded if they have severe cognitive deficits. If patients are hospitalized for more than 2 week during the 6 weeks study period, they will be excluded. Data that were collected before hospitalization will be included in the analysis.

Design outcomes

Primary

MeasureTime frame
The primary outcome will be average and worst pain intensity, measured on the widely used numeric rating scale from 0 (no pain) to 10 (worst imaginable pain) measured at T0, T1 und T2 (T0 before, T1 one week and T2 six weeks after discharge).

Secondary

MeasureTime frame
The number of patients with pain as chief symptom, side-effects (MSAS), patient satisfaction with pain management and information about pain management (numeric rating scale), pain interference with function (BPI), adherence with analgesic medication (numeric rating scale) and the APNpain’s recommendations, quality of life (SF-12), knowledge and attitudes towards pain management (BQII), as well as pain-related self-efficacy (FESS) will be assessed as secondary outcomes. To assess feasibility, semi structured field notes and qualitative interviews will be analyzed. The field notes will be kept at each contact including time and content of the intervention as well as information about any experiences with the intervention procedures and content. The participants’ experiences with pain self-management support and their view of burden and benefit from study participation will be explored in a qualitative substudy. The qualitative interviews will be made with patients in the intervention and the control group. The field notes as well as the qualitative interviews will be analyzed according to the feasibility criteria: Acceptability, demand, implementation, practicality, adaptation, integration, expansion, and limited efficacy (Bowen, et al. [2009]).

Countries

Germany

Contacts

Public ContactAntje Koller

Universitätsklinikum Freiburg

antje.koller@uniklinik-freiburg.de0761 270 34190

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026